Published in Am J Hum Genet on September 11, 2002
Complete MHC haplotype sequencing for common disease gene mapping. Genome Res (2004) 12.09
Mendelian Inheritance in Man and its online version, OMIM. Am J Hum Genet (2007) 9.61
Variation analysis and gene annotation of eight MHC haplotypes: the MHC Haplotype Project. Immunogenetics (2008) 4.25
Genetic analysis of completely sequenced disease-associated MHC haplotypes identifies shuffling of segments in recent human history. PLoS Genet (2006) 2.80
Copy number variants and common disorders: filling the gaps and exploring complexity in genome-wide association studies. PLoS Genet (2007) 2.32
Recent segmental and gene duplications in the mouse genome. Genome Biol (2003) 1.74
Human MHC architecture and evolution: implications for disease association studies. Int J Immunogenet (2008) 1.70
Meiotic recombination generates rich diversity in NK cell receptor genes, alleles, and haplotypes. Genome Res (2009) 1.42
Determining the one, two, three, or four long and short loci of human complement C4 in a major histocompatibility complex haplotype encoding C4A or C4B proteins. Am J Hum Genet (2002) 1.09
Molecular basis of complete complement C4 deficiency in two North-African families with systemic lupus erythematosus. Genes Immun (2009) 1.07
Great genotypic and phenotypic diversities associated with copy-number variations of complement C4 and RP-C4-CYP21-TNX (RCCX) modules: a comparison of Asian-Indian and European American populations. Mol Immunol (2009) 1.07
Phenotypes, genotypes and disease susceptibility associated with gene copy number variations: complement C4 CNVs in European American healthy subjects and those with systemic lupus erythematosus. Cytogenet Genome Res (2009) 1.03
Assessment of complement C4 gene copy number using the paralog ratio test. Hum Mutat (2010) 0.97
Human gene copy number variation and infectious disease. Hum Genet (2014) 0.97
Early Components of the Complement Classical Activation Pathway in Human Systemic Autoimmune Diseases. Front Immunol (2016) 0.88
Accurate measurement of gene copy number for human alpha-defensin DEFA1A3. BMC Genomics (2013) 0.83
Immunoglobulins and complement factor C4 in adult rhinosinusitis. Clin Exp Immunol (2006) 0.82
Confirmation of C4 gene copy number variation and the association with systemic lupus erythematosus in Chinese Han population. Rheumatol Int (2011) 0.81
Gene copy-number variations (CNVs) of complement C4 and C4A deficiency in genetic risk and pathogenesis of juvenile dermatomyositis. Ann Rheum Dis (2015) 0.81
Investigation of complement component C4 copy number variation in human longevity. PLoS One (2014) 0.80
Inactive disease and remission in childhood-onset systemic lupus erythematosus. Arthritis Care Res (Hoboken) (2012) 0.79
Intraspecific evolution of human RCCX copy number variation traced by haplotypes of the CYP21A2 gene. Genome Biol Evol (2013) 0.78
Novel deletion alleles carrying CYP21A1P/A2 chimeric genes in Brazilian patients with 21-hydroxylase deficiency. BMC Med Genet (2010) 0.78
The complement system: a gateway to gene-environment interactions in schizophrenia pathogenesis. Mol Psychiatry (2017) 0.75
The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum (1982) 67.54
Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum (1997) 43.47
Complete sequence and gene map of a human major histocompatibility complex. The MHC sequencing consortium. Nature (1999) 6.07
Congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Endocr Rev (2000) 3.99
Inherited structural polymorphism of the fourth component of human complement. Proc Natl Acad Sci U S A (1980) 3.97
A molecular map of the human major histocompatibility complex class III region linking complement genes C4, C2 and factor B. Nature (1984) 3.27
Two HLA-linked loci controlling the fourth component of human complement. Proc Natl Acad Sci U S A (1978) 3.05
Phenotyping of human complement component C4, a class-III HLA antigen. Biochem J (1986) 2.10
Structural polymorphism of the fourth component of human complement. J Clin Invest (1969) 1.91
Genetic polymorphism of C4 in man and localisation of a structural C4 locus to the HLA gene complex of chromosome 6. Nature (1976) 1.82
Genetic polymorphism of human complement C4 and detection of heterozygotes. Nature (1979) 1.73
A molecular basis for the two locus model of human complement component C4. Nature (1982) 1.65
Structural basis of the polymorphism of human complement components C4A and C4B: gene size, reactivity and antigenicity. EMBO J (1986) 1.54
The dichotomous size variation of human complement C4 genes is mediated by a novel family of endogenous retroviruses, which also establishes species-specific genomic patterns among Old World primates. Immunogenetics (1994) 1.52
The reaction mechanism of the internal thioester in the human complement component C4. Nature (1996) 1.35
Complement polymorphism, the major histocompatibility complex and associated diseases: a speculation. Mol Biol Med (1983) 1.33
Polymorphism of human complement component C4. Immunogenetics (1985) 1.28
Molecular genetics of the fourth component of human complement and steroid 21-hydroxylase. Immunol Rev (1985) 1.27
Human C4 haplotypes with duplicated C4A or C4B. Am J Hum Genet (1984) 1.24
Genetic, structural and functional diversities of human complement components C4A and C4B and their mouse homologues, Slp and C4. Int Immunopharmacol (2001) 1.23
Substitution of a single amino acid (aspartic acid for histidine) converts the functional activity of human complement C4B to C4A. Proc Natl Acad Sci U S A (1990) 1.17
Determining the one, two, three, or four long and short loci of human complement C4 in a major histocompatibility complex haplotype encoding C4A or C4B proteins. Am J Hum Genet (2002) 1.09
A structural model for the location of the Rodgers and the Chido antigenic determinants and their correlation with the human complement component C4A/C4B isotypes. Immunogenetics (1988) 1.06
Reference typing report for complement component C4. Exp Clin Immunogenet (1998) 1.01
Genetics of human C4 polymorphism: detection and segregation of rare and duplicated haplotypes. Immunogenetics (1984) 0.94
The endogenous retroviral insertion in the human complement C4 gene modulates the expression of homologous genes by antisense inhibition. Immunogenetics (2001) 0.94
The molecular basis of complete complement C4A and C4B deficiencies in a systemic lupus erythematosus patient with homozygous C4A and C4B mutant genes. J Immunol (2002) 0.93
Genetic organization of the human MHC class III region. Front Biosci (2001) 0.92
An unequal crossover between the RCCX modules of the human MHC leading to the presence of a CYP21B gene and a tenascin TNXB/TNXA-RP2 recombinant between C4A and C4B genes in a patient with juvenile rheumatoid arthritis. Exp Clin Immunogenet (1999) 0.87
The C4 system: quantitative studies of different genotypes. Immunobiology (1980) 0.86
The study of a French family with two duplicated C4A haplotypes. Hum Genet (1987) 0.85
A novel immunoassay for the quantitation of human C4 gene products. Complement Inflamm (1990) 0.84
Haplotype study on C4 polymorphism in Japanese. Associations with MHC alleles, complotypes, and HLA-complement haplotypes. Immunogenetics (1985) 0.83
Restriction fragment length polymorphisms of the complement component C4 loci on chromosome 6: studies with emphasis on the determination of gene number. Ann Hum Genet (1988) 0.82
Quantitation of the human component C4: definition of C4 Q0 alleles and C4A duplications. Vox Sang (1992) 0.81
The genomic structure of two ancestral haplotypes carrying C4A duplications. Immunogenetics (1991) 0.81
Genetics of human complement component C4 and evolution the central MHC. Front Biosci (2001) 0.80
Characterization of a de novo conversion in human complement C4 gene producing a C4B5-like protein. J Immunol (2002) 0.79
C4 phenotypic variation suggests an unusual class III gene organization. Vox Sang (1985) 0.78
Biological, clinical and population relevance of 95 loci for blood lipids. Nature (2010) 28.21
Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index. Nat Genet (2010) 23.08
Hundreds of variants clustered in genomic loci and biological pathways affect human height. Nature (2010) 20.01
Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study. Lancet (2012) 12.10
Meta-analysis identifies 13 new loci associated with waist-hip ratio and reveals sexual dimorphism in the genetic basis of fat distribution. Nat Genet (2010) 7.94
The adaptor protein MITA links virus-sensing receptors to IRF3 transcription factor activation. Immunity (2008) 7.60
Large-scale association analysis identifies new risk loci for coronary artery disease. Nat Genet (2012) 7.59
A multilocus genetic risk score for coronary heart disease: case-control and prospective cohort analyses. Lancet (2010) 6.07
Mutations in SYNGAP1 in autosomal nonsyndromic mental retardation. N Engl J Med (2009) 3.88
Hyperspectral remote sensing of foliar nitrogen content. Proc Natl Acad Sci U S A (2012) 3.87
Direct measure of the de novo mutation rate in autism and schizophrenia cohorts. Am J Hum Genet (2010) 3.69
Commensal bacteria regulate Toll-like receptor 3-dependent inflammation after skin injury. Nat Med (2009) 3.32
Genome-wide meta-analysis identifies 11 new loci for anthropometric traits and provides insights into genetic architecture. Nat Genet (2013) 3.25
Novel loci for adiponectin levels and their influence on type 2 diabetes and metabolic traits: a multi-ethnic meta-analysis of 45,891 individuals. PLoS Genet (2012) 3.21
Steatosis and liver cancer in transgenic mice expressing the structural and nonstructural proteins of hepatitis C virus. Gastroenterology (2002) 3.02
Sex-stratified genome-wide association studies including 270,000 individuals show sexual dimorphism in genetic loci for anthropometric traits. PLoS Genet (2013) 2.83
Cell cycle regulation in the postmitotic neuron: oxymoron or new biology? Nat Rev Neurosci (2007) 2.75
Apatinib for chemotherapy-refractory advanced metastatic gastric cancer: results from a randomized, placebo-controlled, parallel-arm, phase II trial. J Clin Oncol (2013) 2.69
Chinese physicians and their smoking knowledge, attitudes, and practices. Am J Prev Med (2007) 2.32
Validation and clinical significance of the Childhood Myositis Assessment Scale for assessment of muscle function in the juvenile idiopathic inflammatory myopathies. Arthritis Rheum (2004) 2.31
Methods of the International Tobacco Control (ITC) China Survey. Tob Control (2009) 2.30
BRAF inhibition increases tumor infiltration by T cells and enhances the antitumor activity of adoptive immunotherapy in mice. Clin Cancer Res (2012) 2.28
PD-1 blockade enhances T-cell migration to tumors by elevating IFN-γ inducible chemokines. Cancer Res (2012) 2.23
The ubiquitin ligase RNF5 regulates antiviral responses by mediating degradation of the adaptor protein MITA. Immunity (2009) 2.21
Insulin acutely decreases hepatic fatty acid synthase activity. Cell Metab (2005) 1.99
Tissue inhibitor of metalloproteinase-3 downregulation in lymphangioleiomyomatosis: potential consequence of abnormal serum response factor expression. Am J Respir Cell Mol Biol (2003) 1.93
CEACAM1 regulates insulin clearance in liver. Nat Genet (2002) 1.92
Forecasting global generation of obsolete personal computers. Environ Sci Technol (2010) 1.89
Development of consensus treatment plans for juvenile localized scleroderma: a roadmap toward comparative effectiveness studies in juvenile localized scleroderma. Arthritis Care Res (Hoboken) (2012) 1.84
Anakinra as first-line disease-modifying therapy in systemic juvenile idiopathic arthritis: report of forty-six patients from an international multicenter series. Arthritis Rheum (2011) 1.79
Association of a functional IRF7 variant with systemic lupus erythematosus. Arthritis Rheum (2011) 1.78
Susac's syndrome: 1975-2005 microangiopathy/autoimmune endotheliopathy. J Neurol Sci (2007) 1.76
Increased sensitivity of the European medicines agency algorithm for classification of childhood granulomatosis with polyangiitis. J Rheumatol (2012) 1.70
Extensive DNA damage-induced sumoylation contributes to replication and repair and acts in addition to the mec1 checkpoint. Mol Cell (2012) 1.70
The Relationship between auxin transport and maize branching. Plant Physiol (2008) 1.68
Effectively measuring adherence to medications for systemic lupus erythematosus in a clinical setting. Arthritis Rheum (2007) 1.66
Findings from 2010 Global Adult Tobacco Survey: implementation of MPOWER policy in China. Biomed Environ Sci (2010) 1.65
Sex-specific association of X-linked Toll-like receptor 7 (TLR7) with male systemic lupus erythematosus. Proc Natl Acad Sci U S A (2010) 1.63
Down-regulation of myeloid cell leukemia-1 through inhibiting Erk/Pin 1 pathway by sorafenib facilitates chemosensitization in breast cancer. Cancer Res (2008) 1.56
Effect of intravenous proton pump inhibitor regimens and timing of endoscopy on clinical outcomes of peptic ulcer bleeding. J Gastroenterol Hepatol (2012) 1.51
Trial of early aggressive therapy in polyarticular juvenile idiopathic arthritis. Arthritis Rheum (2011) 1.51
Demethylation of TNFSF7 contributes to CD70 overexpression in CD4+ T cells from patients with systemic sclerosis. Clin Immunol (2012) 1.48
Association of TLR4 gene non-missense single nucleotide polymorphisms with rheumatoid arthritis in Chinese Han population. Rheumatol Int (2012) 1.45
Posttreatment plasma VEGF levels may be associated with the overall survival of patients with advanced non-small cell lung cancer treated with bevacizumab plus chemotherapy. Med Oncol (2011) 1.44
Experimental realization of self-guiding unidirectional electromagnetic edge states. Phys Rev Lett (2011) 1.42
Population-based survey of secondhand smoke exposure in China. Biomed Environ Sci (2010) 1.40
Activation of the nonreceptor protein tyrosine kinase Ack by multiple extracellular stimuli. Proc Natl Acad Sci U S A (2006) 1.37
Premature atherosclerosis in pediatric systemic lupus erythematosus: risk factors for increased carotid intima-media thickness in the atherosclerosis prevention in pediatric lupus erythematosus cohort. Arthritis Rheum (2009) 1.37
Microsaccadic efficacy and contribution to foveal and peripheral vision. J Neurosci (2012) 1.36
Targeted expression of BikDD eradicates pancreatic tumors in noninvasive imaging models. Cancer Cell (2007) 1.35
The localized scleroderma skin severity index and physician global assessment of disease activity: a work in progress toward development of localized scleroderma outcome measures. J Rheumatol (2009) 1.35
Severe epilepsy resulting from genetic interaction between Scn2a and Kcnq2. Hum Mol Genet (2006) 1.34
Protocols for the initial treatment of moderately severe juvenile dermatomyositis: results of a Children's Arthritis and Rheumatology Research Alliance Consensus Conference. Arthritis Care Res (Hoboken) (2010) 1.32
Structural and functional analysis of VQ motif-containing proteins in Arabidopsis as interacting proteins of WRKY transcription factors. Plant Physiol (2012) 1.32
Nuclear localization of Cdk5 is a key determinant in the postmitotic state of neurons. Proc Natl Acad Sci U S A (2008) 1.31
Damage extent and predictors in adult and juvenile dermatomyositis and polymyositis as determined with the myositis damage index. Arthritis Rheum (2009) 1.30
Health status of patients with juvenile rheumatoid arthritis at 1 and 5 years after diagnosis. J Rheumatol (2003) 1.28
Transduction of tumor-specific T cells with CXCR2 chemokine receptor improves migration to tumor and antitumor immune responses. Clin Cancer Res (2010) 1.27
Protein-protein interactions in the regulation of WRKY transcription factors. Mol Plant (2013) 1.26
A dinucleotide deletion in CD24 confers protection against autoimmune diseases. PLoS Genet (2007) 1.25
Advancing cell biology and functional genomics in maize using fluorescent protein-tagged lines. Plant Physiol (2009) 1.25
A spontaneous mutation involving Kcnq2 (Kv7.2) reduces M-current density and spike frequency adaptation in mouse CA1 neurons. J Neurosci (2006) 1.24
Diversity in intrinsic strengths of the human complement system: serum C4 protein concentrations correlate with C4 gene size and polygenic variations, hemolytic activities, and body mass index. J Immunol (2003) 1.24
Association study of genetic variants in eight genes/loci with type 2 diabetes in a Han Chinese population. BMC Med Genet (2010) 1.24
Circulating betatrophin levels are increased in patients with type 2 diabetes and associated with insulin resistance. J Clin Endocrinol Metab (2015) 1.24
Architecture of the Smc5/6 Complex of Saccharomyces cerevisiae Reveals a Unique Interaction between the Nse5-6 Subcomplex and the Hinge Regions of Smc5 and Smc6. J Biol Chem (2009) 1.23
NSAIDs prevent, but do not reverse, neuronal cell cycle reentry in a mouse model of Alzheimer disease. J Clin Invest (2009) 1.23
Urine podocyte mRNAs, proteinuria, and progression in human glomerular diseases. J Am Soc Nephrol (2013) 1.20
Loss of has-miR-337-3p expression is associated with lymph node metastasis of human gastric cancer. J Exp Clin Cancer Res (2013) 1.19
Biomarker discovery in human SLE nephritis. Bull NYU Hosp Jt Dis (2007) 1.18
A high-throughput screening system for Arabidopsis transcription factors and its application to Med25-dependent transcriptional regulation. Mol Plant (2011) 1.18
SUMOylation regulates telomere length homeostasis by targeting Cdc13. Nat Struct Mol Biol (2011) 1.17
The genus Epimedium: an ethnopharmacological and phytochemical review. J Ethnopharmacol (2011) 1.16
The intricate role of complement component C4 in human systemic lupus erythematosus. Curr Dir Autoimmun (2004) 1.15
Association of a common complement receptor 2 haplotype with increased risk of systemic lupus erythematosus. Proc Natl Acad Sci U S A (2007) 1.13
WU and KI polyomavirus present in the respiratory tract of children, but not in immunocompetent adults. J Clin Virol (2008) 1.12
IL-2 therapy promotes suppressive ICOS+ Treg expansion in melanoma patients. J Clin Invest (2014) 1.12
Antitumor activity of selective MEK1/2 inhibitor AZD6244 in combination with PI3K/mTOR inhibitor BEZ235 in gefitinib-resistant NSCLC xenograft models. J Exp Clin Cancer Res (2014) 1.12
A rostrocaudal muscular dystrophy caused by a defect in choline kinase beta, the first enzyme in phosphatidylcholine biosynthesis. J Biol Chem (2005) 1.12
Mannose-binding lectin 2 gene polymorphism in recurrent herpes simplex virus 2 infection. Hum Immunol (2009) 1.10
Treatment of pediatric localized scleroderma: results of a survey of North American pediatric rheumatologists. J Rheumatol (2009) 1.10
An efficient synthesis of hydantoins via sustainable integration of coupled domino processes. Org Lett (2010) 1.10
Large conductance, Ca2+-activated K+ channels (BKCa) and arteriolar myogenic signaling. FEBS Lett (2010) 1.10
Health-related quality of life and its relationship to patient disease course in childhood-onset systemic lupus erythematosus. J Rheumatol (2009) 1.10
Spatial distribution and mechanical function of elastin in resistance arteries: a role in bearing longitudinal stress. Arterioscler Thromb Vasc Biol (2011) 1.09
Preliminary validation and clinical meaning of the Cutaneous Assessment Tool in juvenile dermatomyositis. Arthritis Rheum (2008) 1.09
Isoprenoid biosynthesis as a drug target: bisphosphonate inhibition of Escherichia coli K12 growth and synergistic effects of fosmidomycin. J Med Chem (2006) 1.09
Determining the one, two, three, or four long and short loci of human complement C4 in a major histocompatibility complex haplotype encoding C4A or C4B proteins. Am J Hum Genet (2002) 1.09